GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Forward Pharma A/S (OTCPK:FWPAY) » Definitions » Selling, General, & Admin. Expense

Forward Pharma A/S (Forward Pharma A/S) Selling, General, & Admin. Expense : $3.64 Mil (TTM As of Jun. 2022)


View and export this data going back to 2014. Start your Free Trial

What is Forward Pharma A/S Selling, General, & Admin. Expense?

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Forward Pharma A/S's selling, general, & admin. expense for the six months ended in Jun. 2022 was $1.76 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Jun. 2022 was $3.64 Mil.


Forward Pharma A/S Selling, General, & Admin. Expense Historical Data

The historical data trend for Forward Pharma A/S's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Forward Pharma A/S Selling, General, & Admin. Expense Chart

Forward Pharma A/S Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Selling, General, & Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.11 9.54 4.23 3.06 3.65

Forward Pharma A/S Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.79 1.27 1.76 1.89 1.76

Competitive Comparison of Forward Pharma A/S's Selling, General, & Admin. Expense

For the Biotechnology subindustry, Forward Pharma A/S's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Forward Pharma A/S's Selling, General, & Admin. Expense Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Forward Pharma A/S's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Forward Pharma A/S's Selling, General, & Admin. Expense falls into.



Forward Pharma A/S Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $3.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Forward Pharma A/S  (OTCPK:FWPAY) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Forward Pharma A/S Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of Forward Pharma A/S's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Forward Pharma A/S (Forward Pharma A/S) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Ostergade 24A, 1st Floor, Copenhagen, DNK, 1100
Forward Pharma A/S is a biopharmaceutical company that engages in the research and production of medicinal treatments for multiple sclerosis and psoriasis.